» Articles » PMID: 29474444

Epitopes for Neutralizing Antibodies Induced by HIV-1 Envelope Glycoprotein BG505 SOSIP Trimers in Rabbits and Macaques

Abstract

The native-like, soluble SOSIP.664 trimer based on the BG505 clade A env gene of HIV-1 is immunogenic in various animal species, of which the most studied are rabbits and rhesus macaques. The trimer induces autologous neutralizing antibodies (NAbs) consistently but at a wide range of titers and with incompletely determined specificities. A precise delineation of immunogenic neutralization epitopes on native-like trimers could help strategies to extend the NAb response to heterologous HIV-1 strains. One autologous NAb epitope on the BG505 Env trimer is known to involve residues lining a hole in the glycan shield that is blocked by adding a glycan at either residue 241 or 289. This glycan-hole epitope accounts for the NAb response of most trimer-immunized rabbits but not for that of a substantial subset. Here, we have used a large panel of mutant BG505 Env-pseudotyped viruses to define additional sites. A frequently immunogenic epitope in rabbits is blocked by adding a glycan at residue 465 near the junction of the gp120 V5 loop and β24 strand and is influenced by amino-acid changes in the structurally nearby C3 region. We name this new site the "C3/465 epitope". Of note is that the C3 region was under selection pressure in the infected infant from whom the BG505 virus was isolated. A third NAb epitope is located in the V1 region of gp120, although it is rarely immunogenic. In macaques, NAb responses induced by BG505 SOSIP trimers are more often directed at the C3/465 epitope than the 241/289-glycan hole.

Citing Articles

Vaccination with mRNA-encoded membrane-bound HIV Envelope trimer induces neutralizing antibodies in animal models.

Ramezani-Rad P, Cottrell C, Marina-Zarate E, Liguori A, Landais E, Torres J bioRxiv. 2025; .

PMID: 39896562 PMC: 11785158. DOI: 10.1101/2025.01.24.634423.


Induction of Tier 2 HIV-Neutralizing IgA Antibodies in Rhesus Macaques Vaccinated with BG505.664 SOSIP.

Smith J, Arunachalam P, Legere T, Cavacini L, Hunter E, Pulendran B Vaccines (Basel). 2025; 12(12.

PMID: 39772048 PMC: 11680376. DOI: 10.3390/vaccines12121386.


Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.

Ding H, Nguyen H, Li W, Deshpande A, Zhang S, Jiang F J Virol. 2024; 98(12):e0172024.

PMID: 39508605 PMC: 11650979. DOI: 10.1128/jvi.01720-24.


Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.

Hahn W, Parks K, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L J Exp Med. 2024; 221(10).

PMID: 39235529 PMC: 11380150. DOI: 10.1084/jem.20240604.


Vaccines combining slow delivery and follicle targeting of antigens increase germinal center B cell clonal diversity and clonal expansion.

Rodrigues K, Zhang Y, Aung A, Morgan D, Maiorino L, Yousefpour P bioRxiv. 2024; .

PMID: 39229011 PMC: 11370361. DOI: 10.1101/2024.08.19.608655.


References
1.
Starcich B, Hahn B, Shaw G, McNeely P, Modrow S, Wolf H . Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell. 1986; 45(5):637-48. DOI: 10.1016/0092-8674(86)90778-6. View

2.
Pauthner M, Havenar-Daughton C, Sok D, Nkolola J, Bastidas R, Boopathy A . Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. Immunity. 2017; 46(6):1073-1088.e6. PMC: 5483234. DOI: 10.1016/j.immuni.2017.05.007. View

3.
Modrow S, Hahn B, Shaw G, Gallo R, Wong-Staal F, Wolf H . Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol. 1987; 61(2):570-8. PMC: 253982. DOI: 10.1128/JVI.61.2.570-578.1987. View

4.
Sanders R, Derking R, Cupo A, Julien J, Yasmeen A, de Val N . A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 2013; 9(9):e1003618. PMC: 3777863. DOI: 10.1371/journal.ppat.1003618. View

5.
Moore P, Ranchobe N, Lambson B, Gray E, Cave E, Abrahams M . Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog. 2009; 5(9):e1000598. PMC: 2742164. DOI: 10.1371/journal.ppat.1000598. View